ResMed Inc.
NYSEResMed heads into its July 30 earnings print with an unusual backdrop: the stock has rallied 13% in a month yet analysts keep trimming their targets, short interest is near a 30-day high, and the options market shows an entrenched put-heavy structure that hasn't budged despite the price recovery. The positioning picture is the most striking part of the setup. Short interest has…
Snapshot as of 19 Jul 2026
ResMed heads into its July 30 earnings print with an unusual backdrop: the stock has rallied 13% in a month yet analysts keep trimming their targets, short interest is near a 30-day high, and the options market shows…
ResMed enters the back half of June with a fresh downgrade from a bellwether bank landing just as short sellers are pulling back — a split signal that makes the stock's next move harder to read than usual. The analyst…
RMD heads into the first week of June under mounting pressure — the stock down 12% in seven days, short interest hitting a six-week high, and options traders the most defensively positioned in months. The short-side…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RMD — free to start on ORTEX.
Sign up for free →Open RMD on ORTEX